← Leaderboards
Homayon Ghiasi
Cedars-Sinai Medical Center
$23,295,165
Attributed
$24,139,206
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,139,206 · 11
By mechanism
R01$23,699,587 · 9
R21$438,900 · 1
M01$719 · 1
Top collaborators
- Alexander V Ljubimov4 shared
Most similar at Cedars-Sinai Medical Center
Same institution · by research overlap
- Alexander V Ljubimov$16,915,625
- Steven L Wechsler$12,074,225
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusInfectionSimplexvirusResponsePlayImmune ResponseEye InfectionsEye DiseasesBlindnessRecombinantsRecurrenceViralReactivation From LatencyPublishingCellsCorneaGenesVirus ReplicationPreventHerpesvirus 1T-LymphocyteRecombinant VirusAffectImmune
Grant awards (67)
Role of type 1 IFN in eye infection$470,543
R01 · FY2025 · EY · contact PI
Ocular HSV: Mechanism of virus reactivation$417,500
R01 · FY2025 · EY · contact PI
Therapeutic control of HSK by CD80$417,500
R01 · FY2025 · EY · contact PI
Role of Macrophages in control of Ocular HSV$340,305
R01 · FY2025 · EY · contact PI
Role of type 1 IFN in eye infection$470,543
R01 · FY2024 · EY · contact PI
Therapeutic control of HSK by CD80$417,500
R01 · FY2024 · EY · contact PI
Ocular HSV: Mechanism of virus reactivation$417,500
R01 · FY2024 · EY · contact PI
The Role of gK in HSV-1 Induced Corneal Scarring$417,500
R01 · FY2024 · EY · contact PI
Role of Macrophages in control of Ocular HSV$344,187
R01 · FY2024 · EY · contact PI
Role of type 1 IFN in eye infection$470,543
R01 · FY2023 · EY · contact PI
The Role of gK in HSV-1 Induced Corneal Scarring$417,500
R01 · FY2023 · EY · contact PI
Ocular HSV: Mechanism of virus reactivation$417,500
R01 · FY2023 · EY · contact PI
Therapeutic control of HSK by CD80$417,500
R01 · FY2023 · EY · contact PI
Role of type 2 Innate Lymphoid Cells (ILC2s) in optic neuritis$427,982
R01 · FY2022 · EY · contact PI
The Role of gK in HSV-1 Induced Corneal Scarring$404,975
R01 · FY2022 · EY · contact PI
Therapeutic control of HSK by CD80$404,975
R01 · FY2022 · EY · contact PI
Role of type 2 Innate Lymphoid Cells (ILC2s) in optic neuritis$427,983
R01 · FY2021 · EY · contact PI
Therapeutic control of HSK by CD80$417,500
R01 · FY2021 · EY · contact PI
The Role of gK in HSV-1 Induced Corneal Scarring$417,500
R01 · FY2021 · EY · contact PI
Role of macrophages in control of ocular HSV$412,250
R01 · FY2021 · EY · contact PI
Ocular HSV: Mechanism of virus reactivation$412,250
R01 · FY2021 · EY · contact PI
Role of type 2 Innate Lymphoid Cells (ILC2s) in optic neuritis$38,016
R01 · FY2021 · EY · contact PI
Role of type 2 Innate Lymphoid Cells (ILC2s) in optic neuritis$441,220
R01 · FY2020 · EY · contact PI
Role of macrophages in control of ocular HSV$425,000
R01 · FY2020 · EY · contact PI
Ocular HSV: Mechanism of virus reactivation$425,000
R01 · FY2020 · EY · contact PI
Therapeutic control of HSK by CD80$472,500
R01 · FY2019 · EY · contact PI
Role of type 2 Innate Lymphoid Cells (ILC2s) in optic neuritis$441,220
R01 · FY2019 · EY · contact PI
The role of gK in HSV-1 induced corneal scarring$437,500
R01 · FY2019 · EY · contact PI
Role of macrophages in control of ocular HSV$425,000
R01 · FY2019 · EY · contact PI
Ocular HSV: Mechanism of virus reactivation$425,000
R01 · FY2019 · EY · contact PI
Therapeutic control of HSK by CD80$472,500
R01 · FY2018 · EY · contact PI
The role of gK in HSV-1 induced corneal scarring$437,500
R01 · FY2018 · EY · contact PI
Ocular HSV: Mechanism of virus reactivation$425,833
R01 · FY2018 · EY · contact PI
Role of macrophages in control of ocular HSV$425,000
R01 · FY2018 · EY · contact PI
The role of gK in HSV-1 induced corneal scarring$437,500
R01 · FY2017 · EY · contact PI
Role of macrophages in control of ocular HSV$437,500
R01 · FY2017 · EY · contact PI
Therapeutic control of HSK by CD80$393,750
R01 · FY2017 · EY · contact PI
Therapeutic control of HSK by CD80$78,750
R01 · FY2017 · EY · contact PI
The role of gK in HSV-1 induced corneal scarring$437,500
R01 · FY2016 · EY · contact PI
Role of macrophages in control of ocular HSV$437,500
R01 · FY2016 · EY · contact PI
Therapeutic control of HSK by CD80$393,750
R01 · FY2016 · EY · contact PI
Role of macrophages in control of ocular HSV$37,315
R01 · FY2016 · EY · contact PI
Role of macrophages in control of ocular HSV$437,500
R01 · FY2015 · EY · contact PI
The role of gK in HSV-1 induced corneal scarring$409,150
R01 · FY2015 · EY · contact PI
The role of gK in HSV-1 induced corneal scarring$409,150
R01 · FY2014 · EY · contact PI
The role of gK in HSV-1 induced corneal scarring$396,625
R01 · FY2013 · EY · contact PI
Role of lymphoid DCs in HSV-1 latency$232,650
R21 · FY2013 · AI · contact PI
The role of gK in HSV-1 induced corneal scarring$417,500
R01 · FY2012 · EY · contact PI
Role of lymphoid DCs in HSV-1 latency$206,250
R21 · FY2012 · AI · contact PI
The role of gK in HSV-1 induced corneal scarring$361,969
R01 · FY2010 · EY · contact PI
Ocular HSV: Role of virus and IL-2 in Optic neuritis$327,631
R01 · FY2010 · EY · contact PI
The role of gK in HSV-1 induced corneal scarring$365,625
R01 · FY2009 · EY · contact PI
Ocular HSV: Role of virus and IL-2 in Optic neuritis$331,516
R01 · FY2009 · EY · contact PI
Ocular HSV: Role of virus and IL-2 in Optic neuritis$46,243
R01 · FY2009 · EY · contact PI
The role of gK in HSV-1 induced corneal scarring$365,625
R01 · FY2008 · EY · contact PI
Ocular HSV: Role of virus and IL-2 in Optic neuritis$325,429
R01 · FY2008 · EY · contact PI
Innate & adaptive immunities in control of ocular HSV$340,833
R01 · FY2007 · EY · contact PI
Ocular HSV: Role of virus and IL-2 in Optic neuritis$332,604
R01 · FY2007 · EY · contact PI
THE ROLE OF GK IN HSV-1 INDUCED CORNEAL SCARRING$719
M01 · FY2007 · RR · contact PI
Ocular HSV: Role of virus and IL-2 in Optic neuritis$343,066
R01 · FY2006 · EY · contact PI
Innate & adaptive immunities in control of ocular HSV$342,752
R01 · FY2006 · EY · contact PI
Innate &adaptive immunities in control of ocular HSV$351,000
R01 · FY2005 · EY
The Role of gK in HSV-1 Induced Corneal Scarring$267,750
R01 · FY2005 · EY
The Role of gK in HSV-1 Induced Corneal Scarring$267,750
R01 · FY2004 · EY
The Role of gK in HSV-1 Induced Corneal Scarring$267,750
R01 · FY2003 · EY
The Role of gK in HSV-1 Induced Corneal Scarring$267,750
R01 · FY2002 · EY
OCULAR HSV--PROTECTION USING 7 EXPRESSED GLYCOPROTEINS$17,979
R01 · FY2000 · EY